BRIP1 and malignant colon neoplasm: Similarly, in colon cancer, high BRIP1 expression was associated with improved survival outcomes (2975.55 ± 222.49 vs. 2421.43 ± 206.15 days; χ2 = 7.304; p = 0.007) (Figure 2B).